Filter By Category
Archives
Share on -
EDICOTINIB
Generic Name: EDICOTINIB
ABSTRACT -
Edicotinib is an orally available small-molecule inhibitor of colony-stimulating factor-1 receptor (CSF1R/FMS) investigated in inflammatory, neurologic, and oncology settings..
DOSAGE -
Oral study dosing is protocol-specific; monitor dose-limiting toxicities and organ function.
SIDE EEFECTS -
- Nausea, diarrhea, or abdominal discomfort
- Fatigue
- Headache
- Liver-enzyme elevation
- Rash or pruritus
ALLERGIC REACTIONS -
These symptoms may indicate an allergic reaction and require medical attention.
- Rash, urticaria, angioedema, bronchospasm, or anaphylaxis
DRUG INTERACTIONS-
- CYP-mediated interactions require product-specific review
- Other kinase inhibitors may increase overlapping toxicity
- Immunomodulators may alter macrophage-related effects
PREAUTONS–
- Monitor liver function, CBC, infection symptoms, and skin reactions
- Assess pregnancy risk and contraception
- Verify current trial status and protocol
WARNINGS –
- Potential hepatic, hematologic, infectious, and embryo-fetal toxicity associated with kinase inhibitors
Share on -
. Developed by